MY ACCOUNT | NEWSLETTER |

Changes in the use of antimicrobials and the effects on productivity of swine farms in Denmark


Objective

To evaluate changes in antimicrobial consumption and productivity by Danish swine farms during 1992 to 2008.

Sample Population

All Danish swine farms for antimicrobial consumption data and a representative sample of Danish swine herds for productivity data.

Procedures

Antimicrobial consumption by Danish swine farms from 1992 to 2008 was determined and evaluated in light of policies to regulate antimicrobial consumption, changes in disease patterns, and productivity data. Trend analyses of productivity data were conducted before and after a ban on use of antimicrobial growth promoters (AGPs).

Results

Antimicrobial consumption peaked at 100 mg/kg of swine produced in 1992, decreased to 31 mg/kg in 1999, and increased to 49 mg/kg in 2008. Key factors for changes were regulations banning subtherapeutic use of antimicrobials and veterinary profits from the prescription and sale of antimicrobials in 1994 and termination of AGP use by January 2000. Pig production increased from 18.4 to 271 million pigs, and the mean number of pigs per sow per year raised for slaughter increased from 21 in 1992 to 25 in 2007 Average daily gain for weaning (< 35 kg) and finishing (> 35 kg) pigs was higher in 2008 than in 1992, but mortality rates for weaning and finishing pigs were similar in 1992 and 2008.

Conclusions and Clinical Relevance

From 1992 to 2008, antimicrobial consumption per kilogram of pig produced in Denmark decreased by > 50%. Furthermore, there was improvement in productivity, suggesting that long-term swine productivity was not negatively impacted by a ban on AGP use.


Authors: Frank M. Aarestrup, Vibeke F. Jensen, Hanne-Dorthe Emborg, Erik Jacobsen, Henrik C. Wegener

Source: https://avmajournals.avma.org/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Dr. Marjorie Bercier Publishes Study on Novel Diagnostic Approach for Prevalent Elephant Virus

Like0
Dislike0

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Like0
Dislike0

Feline injection site sarcomas

Like0
Dislike0

C-reactive protein concentrations in canine acute pancreatitis

Like0
Dislike0

A retrospective clinical investigation of the safety and adverse effects of pantoprazole in hospitalized ruminants

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top